LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia
PremiumPress ReleasesLENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia
1M ago
Lenz Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Lenz Therapeutics initiated with a Buy at H.C. Wainwright
1M ago
LENZ Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
LENZ Upcoming Earnings Report: What to Expect?
1M ago
LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference
PremiumPress ReleasesLENZ Therapeutics to Present at the Jefferies Global Healthcare Conference
4M ago
Lenz Therapeutics management to meet with Piper Sandler
Premium
The Fly
Lenz Therapeutics management to meet with Piper Sandler
4M ago
Lenz Therapeutics’ Growth at Risk Amid IP Licensing Battles in Competitive Pharma Landscape
Premium
Company Announcements
Lenz Therapeutics’ Growth at Risk Amid IP Licensing Battles in Competitive Pharma Landscape
4M ago
Lenz Therapeutics initiated with an Outperform at Leerink
PremiumThe FlyLenz Therapeutics initiated with an Outperform at Leerink
5M ago
Lenz Therapeutics initiated with an Outperform at William Blair
Premium
The Fly
Lenz Therapeutics initiated with an Outperform at William Blair
5M ago
Lenz Therapeutics initiated with a Buy at Citi
Premium
The Fly
Lenz Therapeutics initiated with a Buy at Citi
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100